Drug delivery vehicles on a nano-engineering perspective

Materials Science and Engineering C

Volumn 41, Issue , 2014, Pages 178-195

  Felice, Betiana ^a,b,c   Prabhakaran, Molamma P ^c   Rodríguez, Andrea P ^a,b   Ramakrishna, Seeram ^c  

^a UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^b Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

biodegradable polymers; cancer; controlled release; Liposomes; nanotechnology; targeted drug delivery

Indexed keywords

DRUG; LIPOSOME; MONOCLONAL ANTIBODY; NANOPARTICLE; POLYMER; SERUM ALBUMIN;

CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; METABOLISM; MICROFLUIDICS; NANOTECHNOLOGY;

ANTIBODIES, MONOCLONAL; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; MICROFLUIDICS; NANOPARTICLES; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS; POLYMERS; SERUM ALBUMIN;

EID: 84900400291     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2014.04.049     Document Type: Review

References (236)

1. J. Folkman How the field of controlled-release technology began, and its central role in the developmenot f angiogenesis research Biomaterials 11 1990 615 618
2. A.S. Hoffman The origins and evolution of "controlled" drug delivery systems J. Control. Release 132 3 2008 153 163
3. H. Okada et al. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers Pharm. Res. 11 1994 1143 1147 (Pubitemid 24259854)
4. A.D. Bangham, M.M. Standish, and J.C. Watkins Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 13 1965 238 252
5. P. Boisseau, and B. Loubaton Nanomedicine, nanotechnology in medicine C. R. Physique 12 2011 620 636
6. J.A. DiMasi, R.W. Hansen, and H.G. Grabowski The price of innovation: new estimates of drug development costs J. Health Econ. 22 2 2003 151 185 (Pubitemid 36279392)
7. K.I. Kaitin Deconstructing the drug development process: the new face of innovation Clin. Pharmacol. Ther. 87 3 2010 356 361
8. A.C. Eifler, and C.S. Thaxton Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study Methods Mol. Biol. 726 2011 325 338
9. R.K. Verma, and S. Garg Current status of drug delivery technologies and future directions Pharm. Technol. On-line 25 2001 1 14
10. J. Adler-Moore, and R.T. Proffitt Am Bisome: liposomal formulation, structure, mechanism of action and pre-clinical experience J. Antimicrob. Chemother. 49 2002 21 30 (Pubitemid 34162653)
11. M.L. Etheridge et al. The big picture on nanomedicine: the state of investigational and approved nanomedicine products Nanomedicine 9 1 2013 1 14
12. F. Canal, J. Sanchis, and M.J. Vicent Polymer-drug conjugates as nano-sized medicines Curr. Opin. Biotechnol. 22 6 2011 894 900
13. A. Aubert-Pouessel et al. In vitro study of GDNF release from biodegradable PLGA microspheres J. Control. Release 95 3 2004 463 475 (Pubitemid 38340497)
14. E. Igarashi Factors affecting toxicity and efficacy of polymeric nanomedicines Toxicol. Appl. Pharmacol. 229 1 2008 121 134
15. T. Lammers et al. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress J. Control. Release 161 2 2012 175 187
16. A. Puri, L.K., B. Smith, J.H. Lee, A. Yavlovich, E. Heldman, and R. Blumenthal Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic Crit. Rev. Ther. Drug Carrier Syst. 26 6 2009 523 580
17. G. Pratt et al. Liposomal Daunorubicin: In Vitro And In Vivo Efficacy In Multiple Myeloma Hematol. Oncol. 16 1998 47 55 (Pubitemid 29083321)
18. M. Benesch, and C. Urban Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments Expert. Opin. Pharmacother. 9 2008 301 309 (Pubitemid 351233737)
19. N.M. Bressler, and S.B. Bressler Photodynamic Therapy with Verteporfin (Visudyne): Impact on Ophthalmology and Visual Sciences Invest. Ophthalmol. Vis. Sci. 41 3 2000 624 628 (Pubitemid 30158868)
20. M. Alam, and C.T. Hartick Extended-Release Epidural Morphine (DepoDur(tm)): An Old Drug with a New Profile Pain Pract. 5 2005 349 359
21. J.E. Frampton, and A.J. Wagstaff Sucrose-Formulated Octocog Alfa A Review of its Use in Patients with Haemophilia A Drugs 68 2008 839 853 (Pubitemid 351550532)
22. L. Boehlke, and J.N. Winter Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug Expert. Opin. Biol. Ther. 6 2006 409 415
23. C.E. Swenson et al. Liposome technology and the development of Myocet TM (liposomal doxorubicin citrate) Breast 2 2001 1 7 (Pubitemid 32529854)
24. K.A. Gelmon et al. Phase I Study of Liposomal Vincristine J. Clin. Oncol. 17 1999 697 705 (Pubitemid 29075259)
25. R.T.P. Poon, and N. Borys Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer Expert. Opin. Pharmacother. 10 2009 333 343
26. B.E. Bax et al. In vitro and in vivo studies with human carrier erythrocytes loaded with polyethylene glycol-conjugated and native adenosine deaminase Br. J. Haematol. 109 2000 549 554 (Pubitemid 30415181)
27. P.A. Dinndorf et al. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL) Oncologist 12 8 2007 991 998 (Pubitemid 47359142)
28. Y.S. Wang et al. Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications Adv. Drug Deliv. Rev. 54 2002 547 570
29. S. Schreiber et al. Maintenance Therapy with Certolizumab Pegol for Crohn's Disease N. Engl. J. Med. 357 2007 239 250 (Pubitemid 47080388)
30. F. Locatelli, and L. Del Vecchio Peginesatide as a new approach for treating anemia of CKD patient: is it like a falling star? Expert. Opin. Pharmacother. 14 2013 1277 1280
31. J.W. Singer Paclitaxel poliglumex (XYOTAX, CT-2103): a macromolecular taxane J. Control. Release 109 1-3 2005 120 126 (Pubitemid 41737258)
32. M.R. Sherman, M.G. Saifer, and F. Perez-Ruiz PEG-uricase in the management of treatment-resistant gout and hyperuricemia Adv. Drug Deliv. Rev. 60 1 2008 59 68 (Pubitemid 350186186)
33. P.R. Hamann et al. Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody-Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia Bioconjug. Chem. 13 2002 47 58 (Pubitemid 34119634)
34. G.A. Wiseman et al. Radioimmunotherapy of Relapsed Non-Hodgkin's Lymphoma with Zevalin, a 9 yttrium Anti-CD20 Monoclonal Antibody Clin. Cancer Res. 5 1999 3281 3286
35. J.M. Vose Bexxar(r): Novel radioimmunotherapy for the treatment of low-grade and transformed low-grade non-Hodgkin's lymphoma Oncology 9 2004 160 172 (Pubitemid 38452115)
36. J. Deckert et al. A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor Blood 322 2013 3500 3510
37. K. Alhareth et al. HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 887-888 2012 128 132
38. H. Chen et al. Nanonization strategies for poorly water-soluble drugs Drug Discov. Today 16 7-8 2011 354 360
39. T.S. Harrison, and K. Goa Low-acting Risperidone. A review of its use in schizophrenia CNS Drugs 18 2004 113 132 (Pubitemid 38293596)
40. M.R. Green et al. Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer Ann. Oncol. 17 8 2006 1263 1268 (Pubitemid 44288216)
41. T.Y. Kim et al. Phase I and pharmacokinetic study of genexol-pm, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies Clin. Cancer Res. 10 2004 3708 3716
42. A. Kumari, S.K. Yadav, and S.C. Yadav Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf. B Biointerfaces 75 1 2010 1 18
43. F. Danhier et al. PLGA-based nanoparticles: an overview of biomedical applications J. Control. Release 161 2 2012 505 522
44. S. Kim et al. Engineered polymers for advanced drug delivery Eur. J. Pharm. Biopharm. 71 3 2009 420 430
45. A. Jaklenec et al. Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds Biomaterials 29 10 2008 1518 1525
46. Z. Wang, and P.C. Ho A nanocapsular combinatorial sequential drug delivery system for antiangiogenesis and anticancer activities Biomaterials 31 27 2010 7115 7123
47. R.D. Hofheinz et al. Liposomal encapsulated anti-cancer drugs Anti-Cancer Drugs 16 2 2005 691 707
48. M.E. Froudarakis et al. Phase 1 Trial of Lipoplatin and Gemcitabine as a Second-line Chemotherapy in Patients With Nonsmall Cell Lung Carcinoma Cancer 113 10 2008 2752 2760
49. J.A. Silverman, and S.R. Deitcher MarqiboC (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine Cancer Chemother. Pharmacol. 71 2013 555 564
50. H.J. Müller et al. Pegylated asparaginase (OncasparTM) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols Br. J. Haematol. 110 2000 379 384
51. H.S. Yoo, and T.G. Park Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer J. Control. Release 70 2001 63 70 (Pubitemid 32144793)
52. J. Park et al. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin Nanomedicine 5 4 2009 410 418
53. J.M. Korth-Bradley et al. Impact of age and gender on the pharmacokinetics of gemtuzumab ozogamicin Pharmacotherapy 21 2001 1175 1180 (Pubitemid 32939090)
54. G.A. Wiseman et al. Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin(tm) radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma Crit. Rev. Oncol. Hematol. 39 2001 181 194 (Pubitemid 32564871)
55. D.W. Nyman et al. Phase I and Pharmacokinetics Trial of ABI-007, a Novel Nanoparticle Formulation of Paclitaxel in Patients With Advanced Nonhematologic Malignancies J. Clin. Oncol. 23 31 2005 7775 7793
56. A.K. Singla, A. Garg, and D. Aggarwal Paclitaxel and its formulations Int. J. Pharm. 235 2002 179 192 (Pubitemid 34185449)
57. N. Faisant, J. Siepmann, and J.P. Benoit PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release Eur. J. Pharm. Sci. 15 2002 355 366 (Pubitemid 34436923)
58. Y. Yeo, and K. Park Control of encapsulation efficiency and initial burst in polymeric microparticle systems Arch. Pharm. Res. 27 2004 1 12 (Pubitemid 43158226)
59. X. Huang, and C.S. Brazel On the importance and mechanism of burst release in matrix-controlled drug delivery systems J. Control. Release 73 2001 121 136 (Pubitemid 32539245)
60. A.S. Hasan et al. Effect of the microencapsulation of nanoparticles on the reduction of burst release Int. J. Pharm. 344 1-2 2007 53 61 (Pubitemid 47464826)
61. Y.Y. Huang, T.W. Chung, and T.W. Tzeng A method using biodegradable polylactides:polyethylene glycol for drug release with reduced initial burst Int. J. Pharm. 182 1999 93 100
62. R. Cheng et al. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery Biomaterials 34 14 2013 3647 3657
63. P. Bawa et al. Stimuli-responsive polymers and their applications in drug delivery Biomed. Mater. 4 2 2009 022001
64. A.T. Stopeck et al. Phase II study of direct intralesional gene transfer of allovectin-7 and HLA-B7/β2-microglobulin DNA-liposome complex, in patients with metastatic melanoma Clin. Cancer Res. 7 2001 2285 2291 (Pubitemid 32751626)
65. R. Chowdhery, and R. Gonzalez Immunologic therapy targeting metastatic melanoma: Allovectin-7(r) Immunotherapy 3 2011 17 21
66. N. Mylonakis et al. Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer Lung Cancer 68 2 2010 240 247
67. T. Ta, and T.M. Porter Thermosensitive liposomes for localized delivery and triggered release of chemotherapy J. Control. Release 169 1-2 2013 112 125
68. D. Schmaljohann Thermo- and pH-responsive polymers in drug delivery Adv. Drug Deliv. Rev. 58 15 2006 1655 1670 (Pubitemid 44830149)
69. I. Tan et al. PEGylated Chromatography: Efficient Bioseparation on Silica Monoliths Grafted with Smart Biocompatible Polymers ACS Appl. Mater. Interfaces 1 9 2009 1869 1872
70. J. Kost, and R. Langer Responsive polymeric delivery systems Adv. Drug Deliv. Rev. 64 2012 327 341
71. A.S. Hoffman Stimuli-responsive polymers: biomedical applications and challenges for clinical translation Adv. Drug Deliv. Rev. 65 1 2013 10 16
72. V. Torchilin Multifunctional and stimuli-sensitive pharmaceutical nanocarriers Eur. J. Pharm. Biopharm. 71 3 2009 431 444
73. C. He et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles Biomaterials 31 13 2010 3657 3666
74. Y.S. Tarahovsky "Smart" liposomal nanocontainers in biology and medicine Biochem. Mosc. 75 7 2010 811 824
75. S.R. MacEwan, D.J. Callahan, and A. Chilkoti Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery Nanomedicine (Lond) 5 5 2010 793 806
76. S. Grund, M. Bauer, and D. Fischer Polymers in Drug Delivery - State of the Art and Future Trends Adv. Eng. 13 3 2011 61 87
77. M. Nakayama et al. Molecular design of biodegradable polymeric micelles for temperature-responsive drug release J. Control. Release 115 2006 46 56 (Pubitemid 44419528)
78. T. Tagami, M.J. Ernsting, and S.D. Li Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system J. Control. Release 154 2011 290 297
79. H. Grüll, and S. Langereis Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound J. Control. Release 161 2012 317 327
80. W.G. Pitt, G.A. Husseini, and B.J. Staples Ultrasonic drug delivery - a general review Expert Opin. Drug Deliv. 1 1 2004 37 56 (Pubitemid 40297955)
81. K. Ninomiyaa et al. Ultrasound-mediated drug delivery using liposomes modified with a thermosensitive polymer Ultrason. Sonochem. 21 2014 310 316
82. A. Schroeder et al. Controlling Liposomal Drug Release with Low Frequency Ultrasound: Mechanism and Feasibility Langmuir 23 2007 4019 4025 (Pubitemid 46581936)
83. G.B. Sukhorukov et al. Nanoengineered Polymer Capsules: Tools for Detection, Controlled Delivery, and Site-Specific Manipulation Small 1 2 2005 194 200 (Pubitemid 43958456)
84. K. Hayashi et al. High-Frequency, Magnetic-Field-Responsive Drug Release from Magnetic Nanoparticle/Organic Hybrid Based on Hyperthermic Effect ACS Appl. Mater. Interfaces 2 7 2010 1903 1911
85. C. Alvarez-Lorenzo, L. Bromberg, and A. Concheiro Light-sensitive Intelligent Drug Delivery Systems Photochem. Photobiol. 85 2009 848 860
86. G. Liu, W. Liu, and C.M. Dong UV- and NIR-responsive polymeric nanomedicines for on-demand drug delivery Polym. Chem. 4 2013 3431 3443
87. N. Fomina, J. Sankaranarayanan, and A. Almutairi Photochemical mechanisms of light-triggered release from nanocarriers Adv. Drug Deliv. Rev. 64 2012 1005 1020
88. J. Babin et al. A New Two-Photon-Sensitive Block Copolymer Nanocarrier Angew. Chem. Int. 48 2009 3329 3332
89. Y. Shen et al. Multifunctioning pH-responsive nanoparticles from hierarchical self-assembly of polymer brush for cancer drug delivery AIChE J. 54 11 2008 2979 2989
90. S. Hao et al. Rapid preparation of pH-sensitive polymeric nanoparticle with high loading capacity using electrospray for oral drug delivery Mater. Sci. Eng. C 33 2013 4562 4567
91. H. Wen et al. pH-responsive composite microspheres based on magnetic mesoporous silica nanoparticle for drug delivery Eur. J. Pharm. Biopharm. 84 2013 91 98
92. E.C. Cho et al. Role of pH-sensitive polymer-liposome complex in enhancing cellular uptake of biologically active drugs Mater. Sci. Eng. C 29 2009 774 778
93. A. Kumar, I.Y. Galaev, and B. Mattiasson Affinity Precipitation of -Amylase Inhibitor from Wheat Meal by Metal Chelate Affinity Binding Using Cu(II)-Loaded Copolymers of 1-Vinylimidazole with -Isopropylacrylamide Biotechnol. Bioeng. 59 1998 695 704 (Pubitemid 28378104)
94. R. de la Rica, D. Aili, and M.M. Stevens Enzyme-responsive nanoparticles for drug release and diagnostics Adv. Drug Deliv. Rev. 64 2012 967 978
95. L. Sun et al. Oral glucose- and pH-sensitive nanocarriers for simulating insulin release in vivo Polym. Chem. 2013 10.1039/C3PY01416A
96. T.M. Allen, and P.R. Cullis Liposomal drug delivery systems: from concept to clinical applications Adv. Drug Deliv. Rev. 65 1 2013 36 48
97. A. Jesorka, and O. Orwar Liposomes: technologies and analytical applications Annu Rev Anal Chem (Palo Alto, Calif) 1 2008 801 832
98. A. Sharma, and U.S. Sharma Liposomes in drug delivery: progress and limitations Int. J. Pharm. 154 1997 123 140 (Pubitemid 27351317)
99. P. Kan et al. A liposomal formulation able to incorporate a high content of Paclitaxel and exert promising anticancer effect J Drug Deliv. 2011 2011 629234
100. E.V. Tazina, K.V. Kostin, and N.A. Oborotova Drug synthesis methods and manufacturing technology. Specific features of drug encapsulation in liposomes (A review) Pharm. Chem. J. 45 2011 481 490
101. Y. Fan, and Q. Zhang Development of liposomal formulations: From concept to clinical investigations Asian J. Pharm. Sci. 8 2 2013 81 87
102. A.R. Mohammed et al. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability Int. J. Pharm. 285 1-2 2004 23 34 (Pubitemid 39361533)
103. M. Yokoyama et al. Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer J. Control. Release 11 1990 269 278
104. W. Li, and F.C. Szoka Jr. Lipid-based nanoparticles for nucleic acid delivery Pharm. Res. 24 3 2007 438 449 (Pubitemid 46295166)
105. C.R. Dass Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection J. Mol. Med. (Berl) 82 9 2004 579 591 (Pubitemid 39312663)
106. M. Morille et al. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting Biomaterials 31 2 2010 321 329
107. S.D. Brown et al. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin J. Am. Chem. Soc. 132 2010 4678 4684
108. B. Duncan, C. Kim, and V.M. Rotello Gold nanoparticle platforms as drug and biomacromolecule delivery systems J. Control. Release 148 1 2010 122 127
109. J.H. Maeng et al. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer Biomaterials 31 18 2010 4995 5006
110. O. Veiseh, J.W. Gunn, and M. Zhang Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging Adv. Drug Deliv. Rev. 62 3 2010 284 304
111. S.Y. Madani et al. A new era of cancer treatment: carbon nanotubes as drug delivery tools Int. J. Nanomedicine 6 2011 2963 2979
112. Z. Liu et al. Drug delivery with carbon nanotubes for in vivo cancer treatment Cancer Res. 68 16 2008 6652 6660
113. J. Forsgren et al. A ceramic drug delivery vehicle for oral administration of highly potent opioids J. Pharm. Sci. 99 1 2010 219 226
114. J.M. Rosenholm, C. Sahlgren, and M. Linden Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles - opportunities & challenges Nanoscale 2 10 2010 1870 1883
115. J.W. Yoo et al. Bio-inspired, bioengineered and biomimetic drug delivery carriers Nat. Rev. Drug Discov. 10 7 2011 521 535
116. M. Shimomura, and T. Sawadaishi Bottom-up strategy of materials fabrication: a new trend in nanotechnology of soft materials Curr. Opin. Colloid Interface Sci. 6 2001 11 16 (Pubitemid 32233060)
117. M. Wacker Nanocarriers for intravenous injection - the long hard road to the market Int. J. Pharm. 457 1 2013 50 62
118. J.L. Arias Liposomes in drug delivery: A patent review (2007-Present) Expert Opin. Ther. Pat. 23 2013 1 16
119. R.A. Demel, S.C. Kinsky, and L.L. Van Deenen Effects of temperatura and colesterol on the glucose premeability of liposomes prepared with natural and synthetic lecithins Biochim. Biophys. Acta 150 1968 655 665
120. S.B. Kaye, and V.J. Richardson Potential of Liposomes as Drug-Carriers in Cancer Chemotherapy: A Review Cancer Chemother. Pharmacol. 3 1979 81 85 (Pubitemid 10225494)
121. S. Vemuri, and C.T. Rhodes Preparation and characterization of liposomes as therapeutics delivery systems: a review Pharm. Acta Helv. 70 1995 95 111
122. J. Senior, and G. Gregoriadis Stability of small unilamellar liposomes in serum and clearance from the circulation: The effect of the phospholipid nd cholesterol components Life Sci. 30 1982 2123 2136 (Pubitemid 12066826)
123. C. Kirby, J. Clarke, and G. Gregoriadis Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro Biochem. J. 186 1980 591 598
124. K. Nagpal, S.K. Singh, and D.N. Mishra Chitosan nanoparticles: A promising system in novel drug delivery Chem. Pharm. Bull. 58 2010 1423 1430
125. J.J. Wang et al. Recent advances of chitosan nanoparticles as drug carriers Int. J. Nanomedicine 6 2011 765 774
126. H. Xin et al. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(varepsilon-caprolactone) nanoparticles: In vitro and in vivo evaluation Int. J. Pharm. 402 1-2 2010 238 247
127. M.T. Peracchia et al. Stealth(r) PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting J. Control. Release 60 1999 121 128 (Pubitemid 29255834)
128. A. Mahapatro, and D.K. Singh Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines J. Nanobiotechnol. 9 2011 55
129. H. Okada et al. Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate Pharm. Res. 8 1991 787 791
130. X. Xu et al. Comparative study of paclitaxel physically encapsulated in and chemically conjugated with PEG-PLA Polym. Adv. Technol. 20 11 2009 843 848
131. D.S. Jain et al. Poly lactic acid (PLA) nanoparticles sustain the cytotoxic action of temozolomide in C6 Glioma cells Biomed. Aging Pathol. 3 4 2013 201 208
132. S. Munier et al. Cationic PLA nanoparticles for DNA delivery: comparison of three surface polycations for DNA binding, protection and transfection properties Colloids Surf. B: Biointerfaces 43 3-4 2005 163 173 (Pubitemid 40909837)
133. S. Acharya, and S.K. Sahoo PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect Adv. Drug Deliv. Rev. 63 3 2011 170 183
134. D.H. Kim, and D.C. Martin Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery Biomaterials 27 15 2006 3031 3037 (Pubitemid 43208929)
135. K. Osada, R.J. Christie, and K. Kataoka Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery J. R. Soc. Interface 6 Suppl. 3 2009 S325 S339
136. F. Dosio et al. Poly(ethylene glycol)-human serum albumin-paclitaxel conjugates: preparation, characterization and pharmacokinetics J. Control. Release 6 2001 107 117 (Pubitemid 32786889)
137. E. Miele et al. Albumin-bound formulation of paclitaxel (Abraxane(r) ABI-007) in the treatment of breast cancer Int. J. Nanomedicine 4 2009 99 105
138. I.N. Desai Nab Technology: A Drug Delivery Platform Utilising Endothelial gp60 Receptor-based Transport and Tumour derived sparee for Targeting Pharmadeals Drug Delivery Report Winter 2007/2008 2007
139. Q. Fu et al. Nanoparticle Albumin-Bound (NAB) Technology is a Promising Method for Anti-Cancer Drug Delivery Recent Pat. Anticancer Drug Discov. 4 2009 262 272
140. H. Wartlick et al. Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles J. Control. Release 96 3 2004 483 495 (Pubitemid 38553926)
141. S.C. Alley, N.M. Okeley, and P.D. Senter Antibody-drug conjugates: targeted drug delivery for cancer Curr. Opin. Chem. Biol. 14 4 2010 529 537
142. S.J. Goldsmith Radioimmunotherapy of lymphoma: Bexxar and Zevalin Semin. Nucl. Med. 40 2 2010 122 135
143. D.C. Julien et al. Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer MAbs 3 5 2011 467 478
144. L. Wang et al. CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma Biomaterials 33 20 2012 5107 5114
145. P.R. Cullis et al. Generating and loading of liposomal systems for drug-delivery applications Adv. Drug Deliv. Rev. 3 1989 267 282 (Pubitemid 19201829)
146. A.L. Weiner Liposomes for protein delivery: Selecting manufacture and development processes Immunomethods 4 1994 201 209 (Pubitemid 24318702)
147. B. Ceht, and D.D. Lasic A Rigorous Theory of Remote Loading of Drugs into Liposomes Langmuir 11 1995 3356 3368
148. A. Fritze et al. Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient Biochim. Biophys. Acta 1758 10 2006 1633 1640 (Pubitemid 44466698)
149. N. Dos Santos et al. pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol Biochim. Biophys. Acta 1661 1 2004 47 60 (Pubitemid 38201570)
150. I.V. Zhigaltsev et al. Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention J. Control. Release 104 1 2005 103 111 (Pubitemid 40615239)
151. E.M. Bolotin et al. Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligando liposomes J. Liposome Res. 4 1994 455 479 (Pubitemid 24130556)
152. S. Sajeesh, and C.P. Sharma Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery Int. J. Pharm. 325 1-2 2006 147 154 (Pubitemid 44573692)
153. G.A. Husseini, and W.G. Pitt Micelles and nanoparticles for ultrasonic drug and gene delivery Adv. Drug Deliv. Rev. 60 10 2008 1137 1152
154. C. Oerlemans et al. Polymeric micelles in anticancer therapy: targeting, imaging and triggered release Pharm. Res. 27 12 2010 2569 2589
155. Y. Zhang, H.F. Chan, and K.W. Leong Advanced materials and processing for drug delivery: the past and the future Adv. Drug Deliv. Rev. 65 1 2013 104 120
156. L. Tayebi, D. Vashaee, and A.N. Parikh Stability of uni- and multillamellar spherical vesicles ChemPhysChem 13 1 2012 314 322
157. E.R. Gillies, and J.M.J. Fréchet Dendrimers and dendritic polymers in drug delivery Drug Discov. Today 10 2005 35 43 (Pubitemid 40164817)
158. Food and Drug Administration Available from: www.accessdata.fda.gov
159. J. Buse, and A. El-Aneed Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances Nanomedicine 5 8 2010 1237 1260
160. D.N. Waterhouse et al. A Comparison of Liposomal Formulations of Doxorubicin with Drug Administered in Free Form Changing Toxicity Profiles Drug Saf. 24 2001 903 920 (Pubitemid 33078196)
161. T.L. Jackson Intracellular Accumulation and Mechanism of Action of Doxorubicin in a Spatio-temporal Tumor Model J. Theor. Biol. 220 2 2003 201 213 (Pubitemid 36027125)
162. G. Minotti et al. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity Pharmacol. Rev. 56 2 2004 185 229 (Pubitemid 38720829)
163. A. Gabizon et al. Enhancement of adriamycin Delivery to Liver Metastatic Cells with Increased Tumoricidal Effect Using Liposomes as Drug Carriers Cancer Res. 43 1983 4730 4735 (Pubitemid 13015850)
164. A. Gabizon et al. Prolonged Circulation Time and Enhanced Accumulation in Malignant Exudates of Doxorubicin Encapsulated in Polyethylene-glycol Coated Liposomes Cancer Res. 54 1994 987 992 (Pubitemid 24085451)
165. O. Lyass et al. Correlation of Toxicity with Pharmacokinetics of Pegylated Liposomal Doxorubicin (Doxil) in Metastatic Breast Carcinoma Cancer 89 2000 1037 1047
166. R. Duncan Polymer conjugates as anticancer nanomedicines Nat. Rev. Cancer 6 9 2006 688 701 (Pubitemid 44286001)
167. M.J. Keating et al. L-Asparaginase and PEG Asparaginase - Past, Present, and Future Leuk. Lymphoma 10 1993 153 157 (Pubitemid 23120982)
168. C.H. Fu, and K.M. Sakamoto PEG-asparaginase Expert. Opin. Pharmacother. 8 12 2007 1977 1984 (Pubitemid 47316151)
169. L. Pollaro, and C. Heinis Strategies to prolong the plasma residence time of peptide drugs MedChemComm 1 5 2010 319
170. H. Harashima et al. Size Dependent Liposome Degradation in Blood: In vivo/In vitro Correlation by Kinetic Modeling J. Drug Target. 3 1995 253 261 (Pubitemid 26032029)
171. M.A. Schubert et al. Role of oxygen in biodegradation of poly(etherurethane urea) elastomers J. Biomed. Mater. Res. 34 1997 519 530 (Pubitemid 27104933)
172. C.S. Ha, and J.A. Gardella Surface Chemistry of Biodegradable Polymers for Drug Delivery Systems Chem. Rev. 105 2005 4205 4232
173. C. Vermehren, K. Jørgensen, and S. Frokjaer Influence of lipopolymer concentration on liposome degradation and blood clearance Int. J. Pharm. 183 1999 13 16 (Pubitemid 29248819)
174. F. Von Burkersroda, L. Schedlb, and A. Göpferich Why degradable polymers undergo surface erosion or bulk erosion Biomaterials 23 2002 4221 4231 (Pubitemid 34814991)
175. A. Göpferich Mechanisms of polymer degradation and erosion Biomaterials 17 1996 103 114 (Pubitemid 26031366)
176. K.A. Athanasiou, G.G. Niederauer, and C.M. Agrawal Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers Biomaterials 17 1996 93 102 (Pubitemid 26031365)
177. E. Kiss, I. Bertoti, and E.I. Vargha-Butler XPS and wettability characterization of modified poly(lactic acid) and poly(lactic/glycolic acid) films J. Colloid Interface Sci. 245 1 2002 91 98 (Pubitemid 34953371)
178. E.J. Cho et al. Tools to Rapidly Produce and Screen Biodegradable Polymer and Sol-gel-Derived Xerogel Formulations Appl. Spectrosc. 56 11 2002 1385 1389
179. A. Göpferich Polymeric bulk erosion Macromolecules 30 1997 2598 2604
180. D.E. Owens III, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 1 2006 93 102 (Pubitemid 41773257)
181. S.D. Li, and L. Huang Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting J. Control. Release 145 3 2010 178 181
182. M. Rosera, D. Fischerb, and T. Kisselb Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats Eur. J. Pharm. Biopharm. 46 1998 255 263
183. B. Rihova Biocompatibility of biomaterials: hemocompatibility, immunocompatiblity and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers Adv. Drug Deliv. Rev. 21 1996 157 176 (Pubitemid 26401716)
184. P. Aggarwal et al. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy Adv. Drug Deliv. Rev. 61 6 2009 428 437
185. F. Alexis et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles Mol. Pharm. 5 2008 505 515
186. A.J. D'Souza, and E.M. Topp Release from polymeric prodrugs: linkages and their degradation J. Pharm. Sci. 93 8 2004 1962 1979 (Pubitemid 39045479)
187. H.S. Choi et al. Renal clearance of quantum dots Nat. Biotechnol. 25 10 2007 1165 1170
188. T. Yamaoka, Y. Tabata, and Y. Ikada Distribution and Tissue Uptake of Poly(ethylene glycol) with Different Molecular Weights after Intravenous Administration to Mice J. Pharm. Sci. 83 1994 601 606 (Pubitemid 24222392)
189. F.M. Veronese, and G. Pasut PEGylation, successful approach to drug delivery Drug Discov. Today 10 21 2005 1451 1458 (Pubitemid 41483874)
190. M.J. Roberts, M.D. Bentley, and J.M. Harris Chemistry for peptide and protein PEGylation Adv. Drug Deliv. Rev. 64 2012 116 127
191. J.M. Harris, and R.B. Chess Effect of PEGylation on pharmaceuticals Nat. Rev. 2 2003 214 221 (Pubitemid 37361666)
192. K. Knop et al. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives Angew. Chem. Int. Ed. Engl. 49 36 2010 6288 6308
193. E. Jäger et al. Self-assembly of biodegradable copolyester and reactive HPMA-based polymers into nanoparticles as an alternative stealth drug delivery system Soft Matter 8 2012 9563 9575
194. S.K. Lai, Y.Y. Wang, and J. Hanes Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues Adv. Drug Deliv. Rev. 61 2 2009 158 171
195. L.M. Ensign, R. Cone, and J. Hanes Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers Adv. Drug Deliv. Rev. 64 2012 557 570
196. R.S. Bhatta et al. Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: In vitro and pharmacokinetics studies Int. J. Pharm. 432 1-2 2012 105 112
197. H. Maeda et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284 (Pubitemid 30122932)
198. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv. Enzym. Regul. 41 2001 189 207
199. G.A. Hughes Nanostructure-mediated drug delivery Nanomedicine 1 1 2005 22 30 (Pubitemid 43963612)
200. P. Kocbek et al. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody J. Control. Release 120 1-2 2007 18 26 (Pubitemid 46874614)
201. A. Cirstoiu-Hapca et al. Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles Int. J. Pharm. 331 2 2007 190 196 (Pubitemid 46216679)
202. H. Kouchakzadeh et al. Optimization of an anti-HER2 monoclonal antibody targeted delivery system using PEGylated human serum albumin nanoparticles Int. J. Pharm. 447 1-2 2013 62 69
203. Y.M. Lu et al. Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles Biomaterials 35 2014 530 537
204. R. Heukers et al. Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles Biomaterials 35 1 2014 601 610
205. H. Lee et al. Apoptotic Epidermal Growth Factor (EGF)-Conjugated Block Copolymer Micelles as a Nanotechnology Platform for Targeted Combination Therapy Mol. Pharm. 4 2007 769 781 (Pubitemid 350004277)
206. K.B. Chalasani et al. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles J. Control. Release 122 2 2007 141 150 (Pubitemid 47361403)
207. T. Hiratsuka et al. Copolymers for hepatocyte-specific targeting carrying galactose and hydrophobic alkyl groups Macromol. Biosci. 8 3 2008 231 238
208. S. Mahajan et al. Receptor Specific Macrophage Targeting by Mannose-Conjugated Gelatin Nanoparticles-An In Vitro and In Vivo Study Curr. Nanosci. 6 2010 413 421
209. S. Dhar et al. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles Proc. Natl. Acad. Sci. U. S. A. 105 45 2008 17356 17361
210. O.C. Farokzhad et al. Nanoparticle-Aptamer Bioconjugates: A New Approach for Targeting Prostate Cancer Cells Cancer Res. 64 2004 7668 7672
211. D.B. Kirpotin et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 66 13 2006 6732 6740 (Pubitemid 44085631)
212. T.M. Allen Ligand-targeted therapeutics in anticancer therapy Nat. Rev. Cancer 2 10 2002 750 763 (Pubitemid 37328910)
213. B.V.N. Nagavarma et al. Different Techniques For Preparation Of Polymeric Nanoparticles - A Review Asian J. Pharm. Clin. Res. 5 2012 16 23
214. P.A. Grabnar, and J. Kristl The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers J. Microencapsul. 28 4 2011 323 335
215. S. Desgouilles et al. The Design of Nanoparticles Obtained by Solvent Evaporation: A Comprehensive Study Langmuir 19 2003 9504 9510
216. D. Lemoine, and V. Preát Polymeric nanoparticles as delivery system for influenza virus glycoproteins J. Control. Release 54 1998 15 27 (Pubitemid 28255234)
217. K. Andreas et al. Biodegradable insulin-loaded PLGA microspheres fabricated by three different emulsification techniques: investigation for cartilage tissue engineering Acta Biomater. 7 4 2011 1485 1495
218. H.Y. Kwon et al. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method Colloids Surf. A 182 2001 123 130
219. C.W. Pouton Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification Int. J. Pharm. 27 1985 335 348 (Pubitemid 16218683)
220. N.M. Belliveau et al. Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA Mol. Ther. Nucleic Acids 1 2012 e37
221. D. van Swaay, and A. deMello Microfluidic methods for forming liposomes Lab Chip 13 5 2013 752 767
222. R. Karnik et al. Microfluidic Platform for Controlled Synthesis of Polymeric Nanoparticles Nano Lett. 8 2008 2906 2912
223. H.C. Shum, J.W. Kim, and D.A. Weitz Microfluidic Fabrication of Monodisperse Biocompatible and Biodegradable Polymersomes with Controlled Permeability J. Am. Chem. Soc. 130 2008 9543 9549 (Pubitemid 352031166)
224. N. Kolishetti et al. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy PNAS 107 2010 17939 17944
225. P.M. Valencia et al. Microfluidic technologies for accelerating the clinical translation of nanoparticles Nat. Nanotechnol. 7 10 2012 623 629
226. N. Bock, T.R. Dargaville, and W.A. Woodruffa Electrospraying of polymers with therapeutic molecules: State of the art Prog. Polym. Sci. 37 2012 1510 1551
227. M. Zamani, M.P. Prabhakaran, and S. Ramakrishna Advances in drug delivery via electrospun and electrosprayed nanomaterials Int. J. Nanomedicine 8 2013 2997 3017
228. A. Gomez et al. Production Of Protein Nanoparticles By Electrospray Drying J. Aerosol Sci. 29 1998 561 574 (Pubitemid 28263563)
229. J. Venugopal, M.P. Prabhakaran, S. Low, A.T. Choon, Y.Z. Zhang, G. Deepika, and S. Ramakrishna Nanotechnology for Nanomedicine and Delivery of Drugs Curr. Pharm. Des. 14 2008 2184 2200
230. J. Venugopal, M.P. Prabhakaran, S. Low, A.T. Choon, G. Deepika, V.R. Giri Dev, and S. Ramakrishna Continuous Nanostructures for the Controlled Release of Drugs Curr. Pharm. Des. 15 2009 1799 1808
231. J. Xie, J.C. Marijnissen, and C.H. Wang Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro Biomaterials 27 17 2006 3321 3332 (Pubitemid 43344343)
232. R. Pareta, and M.J. Edirisinghe A novel method for the preparation of biodegradable microspheres for protein drug delivery J. R. Soc. Interface 3 9 2006 573 582 (Pubitemid 44265161)
233. J. Xie et al. Encapsulation of protein drugs in biodegradable microparticles by co-axial electrospray J. Colloid Interface Sci. 317 2 2008 469 476 (Pubitemid 350116111)
234. H. Valo et al. Electrospray encapsulation of hydrophilic and hydrophobic drugs in poly(L-lactic acid) nanoparticles Small 5 15 2009 1791 1798
235. K. Pancholi et al. Novel electrohydrodynamic preparation of porous chitosan particles for drug delivery J. Mater. Sci. Mater. Med. 20 4 2009 917 923
236. J.M. DeSimone et al. Methods for fabricating isolated micro- and nano-structures using soft of imprint lithography 2004